Scientists have found a new vaccine to be effective against Alzheimer’s disease

News from the web:

Here is some good news about the fight against Alzheimer. Scientist have declared a human trail successful. The new treatment involves active immunisation, using a type of vaccine designed to trigger the body’s immune defence against beta-amyloid.

In this second clinical trial on humans, the vaccine was modified to affect only the harmful beta-amyloid.

The researchers found that 80 per cent of the patients involved in the trials developed their own protective antibodies against beta-amyloid without suffering any side effects over the three years of the study.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Moving forward to prevention

News from the web:

Where the researchers once could only diagnose Alzheimer after a patient’s death with an autopsy, these days we can see the disease progress with brainscans and can treat it with inserting medicine directly into the brain. Yet the best shot at getting Alzheimer under control, while 35 million people worldwide now suffer from this disease, is to switch the efforts to prevention.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Early Onset Alzheimer

News from the web:

An estimated 5.4 million americans suffer from early onset Alzheimer. This represents about 10% of all who suffer from Alzheimer.

  • Severity: The symptoms of Alzheimer’s – memory loss, intellectual and behavioural disorders – take a more aggressive course in younger victims.
  • Speed: Rather than progressing over 10 to 15 years, as is the case with older patients, young-onset Alzheimer’s takes only a few years to reach an advanced stage. Mortality rates vary, but “people usually die after eight years,” says Yves Agid, a renowned neurologist and neuroscientist.

 

Read all about it HERE

visit us at AlzheimerHeadlines.com

Immune system helps with Alzheimer

News from the web:

Researchers have found that a gene called CCR2 can help with fighting memory loss for people with Alzheimer’s disease. This is a very exciting result. It may be that CCR2-associated immunity could be strengthened in humans to slow Alzheimer’s disease. The work is still in it’s early stages but the results should be encouraging.

Read all about it HERE

visit us at AlzheimerHeadlines.com